Recursion outlines $375M 2026 cash OpEx guidance while advancing first Genentech neuroscience target
We are no longer just discussing the potential of our platform." (CEO, President & Director Najat Khan) "We now have 5 clinical stage programs, including REC-4881 in FAP, where we have generated some ...
A mathematician working at Anthropic says he used the AI model Claude Fable 5 to uncover a remarkably simple counterexample ...
Gordon Scott has been an active investor and technical analyst for 20+ years. He is a Chartered Market Technician (CMT). Katrina Ávila Munichiello is an experienced editor, writer, fact-checker, and ...
Collier Jennings is an entertainment journalist with a substantial amount of experience under his belt. Collier, or "CJ" to his friends and family, is a dedicated fan of genre films - particularly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results